Treasurer of the State of North Carolina’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
41,958
+1,327
| +3% | +$48.3K | ﹤0.01% | 934 |
|
|
2025
Q1 | $1.47M | Buy |
40,631
+1,580
| +4% | +$57.2K | 0.01% | 902 |
|
|
2024
Q4 | $1.64M | Sell |
39,051
-330
| -0.8% | -$13.9K | 0.01% | 902 |
|
|
2024
Q3 | $2.19M | Buy |
39,381
+1,410
| +4% | +$78.3K | 0.01% | 869 |
|
|
2024
Q2 | $1.56M | Buy |
37,971
+2,878
| +8% | +$118K | 0.01% | 901 |
|
|
2024
Q1 | $1.64M | Buy |
35,093
+240
| +0.7% | +$11.2K | 0.01% | 884 |
|
|
2023
Q4 | $1.67M | Buy |
34,853
+5,150
| +17% | +$246K | 0.01% | 896 |
|
|
2023
Q3 | $1.06M | Buy |
29,703
+150
| +0.5% | +$5.35K | 0.01% | 946 |
|
|
2023
Q2 | $1.36M | Buy |
29,553
+360
| +1% | +$16.6K | 0.01% | 923 |
|
|
2023
Q1 | $1.17M | Buy |
29,193
+210
| +0.7% | +$8.42K | 0.01% | 924 |
|
|
2022
Q4 | $1.34M | Buy |
28,983
+370
| +1% | +$17.1K | 0.01% | 892 |
|
|
2022
Q3 | $1.19M | Buy |
28,613
+370
| +1% | +$15.3K | 0.01% | 926 |
|
|
2022
Q2 | $1.69M | Buy |
28,243
+4,254
| +18% | +$254K | 0.01% | 869 |
|
|
2022
Q1 | $1.74M | Buy |
23,989
+380
| +2% | +$27.6K | 0.01% | 854 |
|
|
2021
Q4 | $1.99M | Buy |
23,609
+400
| +2% | +$33.6K | 0.01% | 821 |
|
|
2021
Q3 | $2.09M | Buy |
23,209
+779
| +3% | +$70.3K | 0.01% | 803 |
|
|
2021
Q2 | $2.14M | Buy |
+22,430
| New | +$2.14M | 0.01% | 802 |
|